Anti-glypican-3 antibody having improved kinetics in plasma

Details for Australian Patent Application No. 2008305851 (hide)

Owner Chugai Seiyaku Kabushiki Kaisha

Inventors Ishiguro, Takahiro; Shiraiwa, Hirotake; Tachibana, Tatsuhiko; Kuramochi, Taichi; Tsunoda, Hiroyuki; Igawa, Tomoyuki

Agent Pizzeys

Pub. Number AU-A-2008305851

PCT Pub. Number WO2009/041062

Priority 2007-256063 28.09.07 JP

Filing date 26 September 2008

Wipo publication date 2 April 2009

International Classifications

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/041062 Priority application(s): WO2009/041062

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008305887-Ultraviolet absorber

2008305846-Vaccines and vaccine components for inhibition of microbial cells